The Question Is Whether To Buy Or Not To Buy Aurora Cannabis Inc (NASDAQ: ACB)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Aurora Cannabis Commends Germany’s Landmark Legalization Achievement.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

Aurora Cannabis Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Aurora Cannabis Inc is $78.73M. A total of 14.41 million shares were traded on the day, compared to an average of 1.87M shares.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, ACB has a high of $11.50 and a low of $2.84.

As of this writing, ACB has an earnings estimate of -$0.17 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of -$0.04 per share and a lower estimate of -$0.3. The company reported an EPS of $0 in the last quarter, which was 100.00% higher than expectations of -$0.3.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ACB’s latest balance sheet shows that the firm has $439.14M in Cash & Short Term Investments as of fiscal 2022. There were $269.49M in debt and $130.86M in liabilities at the time. Its Book Value Per Share was $8.23, while its Total Shareholder’s Equity was $662.35M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ACB is Buy with a score of 3.33.

Most Popular

Related Posts